Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Quality of life of children with hearing loss in special and mainstream education: A longitudinal study.

van der Straaten TFK, Rieffe C, Soede W, Netten AP, Dirks E, Oudesluys-Murphy AM, Dekker FW, Böhringer S, Frijns JHM; DECIBEL Collaborative study group.

Int J Pediatr Otorhinolaryngol. 2020 Jan;128:109701. doi: 10.1016/j.ijporl.2019.109701. Epub 2019 Oct 5.

PMID:
31606686
2.

Pediatric Auditory Brainstem Implant Users Compared With Cochlear Implant Users With Additional Disabilities.

van der Straaten TFK, Netten AP, Boermans PPBM, Briaire JJ, Scholing E, Koot RW, Malessy MJA, van der Mey AGL, Verbist BM, Frijns JHM.

Otol Neurotol. 2019 Aug;40(7):936-945. doi: 10.1097/MAO.0000000000002306.

PMID:
31295204
3.

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study.

Maagdenberg H, Bierings MB, van Ommen CH, van der Meer FJM, Appel IM, Tamminga RYJ, le Cessie S, Swen JJ, van der Straaten T, de Boer A, Maitland-van der Zee AH.

J Thromb Haemost. 2018 Sep;16(9):1732-1742. doi: 10.1111/jth.14211. Epub 2018 Jul 17.

PMID:
29935043
4.

Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.

Verboom MC, Kloth JSL, Swen JJ, van der Straaten T, Bovée JVMG, Sleijfer S, Reyners AKL, Mathijssen RHJ, Guchelaar HJ, Steeghs N, Gelderblom H.

Eur J Cancer. 2017 Nov;86:226-232. doi: 10.1016/j.ejca.2017.09.025. Epub 2017 Oct 18.

PMID:
29054076
5.

Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer.

Lam SW, van der Noort V, van der Straaten T, Honkoop AH, Peters GJ, Guchelaar HJ, Boven E.

Pharmacol Res. 2018 Feb;128:122-129. doi: 10.1016/j.phrs.2017.08.005. Epub 2017 Aug 18.

PMID:
28827188
6.

Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib.

Kloth JSL, Verboom MC, Swen JJ, van der Straaten T, Sleijfer S, Reyners AKL, Steeghs N, Gelderblom H, Guchelaar HJ, Mathijssen RHJ.

Pharmacogenomics J. 2018 Jan;18(1):49-55. doi: 10.1038/tpj.2016.83. Epub 2017 Jan 24.

PMID:
28117434
7.

Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.

Buermans HP, Vossen RH, Anvar SY, Allard WG, Guchelaar HJ, White SJ, den Dunnen JT, Swen JJ, van der Straaten T.

Hum Mutat. 2017 Mar;38(3):310-316. doi: 10.1002/humu.23166. Epub 2017 Jan 18.

8.

ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.

Zhang G, Guan Y, Zhao Y, van der Straaten T, Xiao S, Xue P, Zhu G, Liu Q, Cai Y, Jin C, Yang J, Wu S, Lu X.

Chem Biol Interact. 2017 Feb 1;263:55-65. doi: 10.1016/j.cbi.2016.12.015. Epub 2016 Dec 24.

PMID:
28027876
9.

Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.

Lam SW, Frederiks CN, van der Straaten T, Honkoop AH, Guchelaar HJ, Boven E.

Br J Cancer. 2016 Nov 22;115(11):1335-1342. doi: 10.1038/bjc.2016.326. Epub 2016 Oct 13.

10.

Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients.

Moes DJ, Press RR, Ackaert O, Ploeger BA, Bemelman FJ, Diack C, Wessels JA, van der Straaten T, Danhof M, Sanders JS, Homan van der Heide JJ, Guchelaar HJ, de Fijter JW.

Br J Clin Pharmacol. 2016 Jul;82(1):227-37. doi: 10.1111/bcp.12946. Epub 2016 May 10.

11.

Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.

van der Weide K, Loovers H, Pondman K, Bogers J, van der Straaten T, Langemeijer E, Cohen D, Commandeur J, van der Weide J.

Pharmacogenomics J. 2017 Oct;17(5):471-478. doi: 10.1038/tpj.2016.32. Epub 2016 May 10.

PMID:
27168101
12.

The ERCC2/XPD Lys751Gln polymorphism affects DNA repair of benzo[a]pyrene induced damage, tested in an in vitro model.

Xiao S, Cui S, Lu X, Guan Y, Li D, Liu Q, Cai Y, Jin C, Yang J, Wu S, van der Straaten T.

Toxicol In Vitro. 2016 Aug;34:300-308. doi: 10.1016/j.tiv.2016.04.015. Epub 2016 Apr 29.

PMID:
27139774
13.

Response: Limited sampling strategies for once daily tacrolimus exposure monitoring.

Moes DJ, Swen JJ, van der Bent SA, van der Straaten T, Inderson A, Olofsen E, Verspaget HW, Guchelaar HJ, den Hartigh J, van Hoek B.

Eur J Clin Pharmacol. 2016 Jun;72(6):775-6. doi: 10.1007/s00228-016-2036-y. Epub 2016 Mar 2. No abstract available.

PMID:
26931555
14.

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

de Groot S, Charehbili A, van Laarhoven HW, Mooyaart AL, Dekker-Ensink NG, van de Ven S, Janssen LG, Swen JJ, Smit VT, Heijns JB, Kessels LW, van der Straaten T, Böhringer S, Gelderblom H, van der Hoeven JJ, Guchelaar HJ, Pijl H, Kroep JR; Dutch Breast Cancer Research Group.

Breast Cancer Res. 2016 Jan 6;18(1):3. doi: 10.1186/s13058-015-0663-3.

15.

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.

Moes DJ, van der Bent SA, Swen JJ, van der Straaten T, Inderson A, Olofsen E, Verspaget HW, Guchelaar HJ, den Hartigh J, van Hoek B.

Eur J Clin Pharmacol. 2016 Feb;72(2):163-74. doi: 10.1007/s00228-015-1963-3. Epub 2015 Oct 31.

16.

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects.

Dezentjé VO, Opdam FL, Gelderblom H, Hartigh den J, Van der Straaten T, Vree R, Maartense E, Smorenburg CH, Putter H, Dieudonné AS, Neven P, Van de Velde CJ, Nortier JW, Guchelaar HJ.

Breast Cancer Res Treat. 2015 Oct;153(3):583-90. doi: 10.1007/s10549-015-3562-5. Epub 2015 Sep 14.

17.

Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia.

Charehbili A, de Groot S, van der Straaten T, Swen JJ, Pijl H, Gelderblom H, van de Velde CJ, Nortier JW, Guchelaar HJ, Kroep JR.

Pharmacogenomics. 2015;16(11):1267-76. doi: 10.2217/PGS.15.74. Epub 2015 Aug 20.

PMID:
26289095
18.

Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.

Pander J, van Huis-Tanja L, Böhringer S, van der Straaten T, Gelderblom H, Punt C, Guchelaar HJ.

PLoS One. 2015 Jul 29;10(7):e0131091. doi: 10.1371/journal.pone.0131091. eCollection 2015.

19.

A misleading false-negative result using Neisseria gonorrhoeae opa MGB multiplex PCR assay in patient's rectal sample due to partial mutations of the opa gene.

Vahidnia A, van Empel PJ, Costa S, Oud RT, van der Straaten T, Bliekendaal H, Spaargaren J.

New Microbiol. 2015 Jul;38(3):431-4. Epub 2015 Jul 6.

20.

GenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian population.

Bank PC, Swen JJ, Guchelaar HJ, van der Straaten T.

Pharmacogenomics. 2015;16(7):681-7. doi: 10.2217/pgs.15.30. Epub 2015 May 1.

PMID:
25929855
21.

FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis.

Dávila-Fajardo CL, van der Straaten T, Baak-Pablo R, Medarde Caballero C, Cabeza Barrera J, Huizinga TW, Guchelaar HJ, Swen JJ.

Pharmacogenomics. 2015;16(4):373-81. doi: 10.2217/pgs.14.178.

PMID:
25823785
22.

High-quality genotyping data from formalin-fixed, paraffin-embedded tissue on the drug metabolizing enzymes and transporters plus array.

Vos HI, van der Straaten T, Coenen MJ, Flucke U, te Loo DM, Guchelaar HJ.

J Mol Diagn. 2015 Jan;17(1):4-9. doi: 10.1016/j.jmoldx.2014.08.003.

23.

Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial.

Fontein DB, Houtsma D, Nortier JW, Baak-Pablo RF, Kranenbarg EM, van der Straaten TR, Putter H, Seynaeve C, Gelderblom H, van de Velde CJ, Guchelaar HJ.

Breast Cancer Res Treat. 2014 Apr;144(3):599-606. doi: 10.1007/s10549-014-2873-2. Epub 2014 Mar 4.

PMID:
24590773
24.

Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation.

Moes DJ, Swen JJ, den Hartigh J, van der Straaten T, van der Heide JJ, Sanders JS, Bemelman FJ, de Fijter JW, Guchelaar HJ.

CPT Pharmacometrics Syst Pharmacol. 2014 Feb 12;3:e100. doi: 10.1038/psp.2013.78.

25.

Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.

Guchelaar HJ, Gelderblom H, van der Straaten T, Schellens JH, Swen JJ.

Clin Pharmacol Ther. 2014 Apr;95(4):383-5. doi: 10.1038/clpt.2014.13. Epub 2014 Jan 21.

PMID:
24448475
26.

Developmental haemostasis: age-specific differences in the quantity of hemostatic proteins: reply to a rebuttal.

Attard C, van der Straaten T, Karlaftis V, Monagle P, Ignjatovic V.

J Thromb Haemost. 2014 Feb;12(2):286. doi: 10.1111/jth.12462. No abstract available.

27.

Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples.

van Huis-Tanja L, Kweekel D, Gelderblom H, Koopman M, Punt K, Guchelaar HJ, van der Straaten T.

Pharmacogenomics. 2013 Dec;14(16):2005-12. doi: 10.2217/pgs.13.169.

PMID:
24279855
28.

CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.

Dezentjé VO, Gelderblom H, Van Schaik RH, Vletter-Bogaartz JM, Van der Straaten T, Wessels JA, Kranenbarg EM, Berns EM, Seynaeve C, Putter H, Van de Velde CJ, Nortier JW, Guchelaar HJ.

Breast Cancer Res Treat. 2014 Jan;143(1):171-9. doi: 10.1007/s10549-013-2777-6. Epub 2013 Nov 22.

PMID:
24265036
29.

Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.

van Huis-Tanja LH, Kweekel DM, Lu X, Franken K, Koopman M, Gelderblom H, Antonini NF, Punt CJ, Guchelaar HJ, van der Straaten T.

Mutat Res. 2014 Jan;759:37-44. doi: 10.1016/j.mrfmmm.2013.11.001. Epub 2013 Nov 9.

PMID:
24220697
30.

Exploratory analysis of 1936 SNPs in ADME genes for association with busulfan clearance in adult hematopoietic stem cell recipients.

Ten Brink MH, Swen JJ, Böhringer S, Wessels JA, van der Straaten T, Marijt EW, von dem Borne PA, Zwaveling J, Guchelaar HJ.

Pharmacogenet Genomics. 2013 Dec;23(12):675-83. doi: 10.1097/FPC.0000000000000007.

PMID:
24192531
31.

Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation.

ten Brink MH, van Bavel T, Swen JJ, van der Straaten T, Bredius RG, Lankester AC, Zwaveling J, Guchelaar HJ.

Pharmacogenomics. 2013 Nov;14(14):1683-90. doi: 10.2217/pgs.13.159.

PMID:
24192117
32.

A novel specific pyrosequencing method for genotyping FCGR3A rs396991 without coamplification of homologous gene FCGR3B.

van der Straaten T, Martijn R, el Hajoui T, Baak-Pablo R, Guchelaar HJ.

Pharmacogenet Genomics. 2013 Nov;23(11):631-5. doi: 10.1097/FPC.0b013e328365a4f2.

PMID:
24061201
33.

Developmental hemostasis: age-specific differences in the levels of hemostatic proteins.

Attard C, van der Straaten T, Karlaftis V, Monagle P, Ignjatovic V.

J Thromb Haemost. 2013 Oct;11(10):1850-4. doi: 10.1111/jth.12372. Erratum in: J Thromb Haemost. 2019 Nov;17(11):1995.

34.

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.

Dezentjé VO, van Schaik RH, Vletter-Bogaartz JM, van der Straaten T, Wessels JA, Kranenbarg EM, Berns EM, Seynaeve C, Putter H, van de Velde CJ, Nortier JW, Gelderblom H, Guchelaar HJ.

Breast Cancer Res Treat. 2013 Jul;140(2):363-73. doi: 10.1007/s10549-013-2619-6. Epub 2013 Jul 11.

PMID:
23842856
35.

Plasmid derived external quality controls for genetic testing.

van der Straaten T, Guchelaar HJ.

Methods Mol Biol. 2013;1015:189-97. doi: 10.1007/978-1-62703-435-7_12.

PMID:
23824857
36.

Relationship between the functional exon 3 deleted growth hormone receptor polymorphism and symptomatic osteoarthritis in women.

Claessen KM, Kloppenburg M, Kroon HM, Bijsterbosch J, Pereira AM, Romijn JA, van der Straaten T, Nelissen RG, Hofman A, Uitterlinden AG, Duijnisveld BJ, Lakenberg N, Beekman M, van Meurs JB, Slagboom PE, Biermasz NR, Meulenbelt I.

Ann Rheum Dis. 2014 Feb;73(2):433-6. doi: 10.1136/annrheumdis-2012-202713. Epub 2013 Jun 5.

PMID:
23740230
37.

Pharmacogenetics in transplant patients: mind the mix.

Ten Brink MH, van der Straaten T, Bouwsma H, Baak-Pablo R, Guchelaar HJ, Swen JJ.

Clin Pharmacol Ther. 2013 Oct;94(4):443-4. doi: 10.1038/clpt.2013.110. Epub 2013 May 24. No abstract available.

PMID:
23708744
38.

ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.

Lu X, Liu Y, Yu T, Xiao S, Bao X, Pan L, Zhu G, Cai Y, Liu Q, Jin C, Yang J, Wu S, An L, van der Straaten T.

PLoS One. 2013 Apr 4;8(4):e60006. doi: 10.1371/journal.pone.0060006. Print 2013.

39.

Excision repair of BPDE-adducts in human lymphocytes: diminished capacity associated with ERCC1 C8092A (rs3212986) polymorphism.

Yu T, Liu Y, Lu X, Xiao S, Cai Y, Jin C, Liu Q, Yang J, Wu S, Bao X, Pan L, van der Straaten T.

Arch Toxicol. 2013 Apr;87(4):699-709. doi: 10.1007/s00204-012-0986-0. Epub 2012 Dec 1.

PMID:
23203453
40.

Population pharmacokinetics and pharmacogenetics of everolimus in renal transplant patients.

Moes DJ, Press RR, den Hartigh J, van der Straaten T, de Fijter JW, Guchelaar HJ.

Clin Pharmacokinet. 2012 Jul 1;51(7):467-80. doi: 10.2165/11599710-000000000-00000.

PMID:
22624503
41.

The challenges of developing a 'medical-grade' genome.

van der Straaten T, Guchelaar HJ, Swen JJ.

Pharmacogenomics. 2012 Mar;13(4):369-72. doi: 10.2217/pgs.12.6. No abstract available.

PMID:
22379992
42.
43.

Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β gene.

Swen JJ, Baak-Pablo RF, Guchelaar HJ, van der Straaten T.

Clin Chem Lab Med. 2011 Oct 21;50(2):279-84. doi: 10.1515/CCLM.2011.758.

PMID:
22022982
44.

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.

Swen JJ, van der Straaten T, Wessels JA, Bouvy ML, Vlassak EE, Assendelft WJ, Guchelaar HJ.

Eur J Clin Pharmacol. 2012 Apr;68(4):363-70. doi: 10.1007/s00228-011-1130-4. Epub 2011 Oct 8.

45.

Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab.

Pander J, Heusinkveld M, van der Straaten T, Jordanova ES, Baak-Pablo R, Gelderblom H, Morreau H, van der Burg SH, Guchelaar HJ, van Hall T.

Clin Cancer Res. 2011 Sep 1;17(17):5668-73. doi: 10.1158/1078-0432.CCR-11-0239. Epub 2011 Jul 25.

46.

Evidence for qualified quantitative mRNA analysis in formalin-fixed and paraffin-embedded colorectal carcinoma cells and tissue.

Lu X, van der Straaten T, Tiller M, Li X.

J Clin Lab Anal. 2011;25(3):166-73. doi: 10.1002/jcla.20451.

47.

Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT.

ten Brink MH, Wessels JA, den Hartigh J, van der Straaten T, von dem Borne PA, Guchelaar HJ, Zwaveling J.

Bone Marrow Transplant. 2012 Feb;47(2):190-5. doi: 10.1038/bmt.2011.55. Epub 2011 Mar 28.

PMID:
21441958
48.

Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients.

Lemos C, Giovannetti E, Zucali PA, Assaraf YG, Scheffer GL, van der Straaten T, D'Incecco A, Falcone A, Guchelaar HJ, Danesi R, Santoro A, Giaccone G, Tibaldi C, Peters GJ.

Pharmacogenomics. 2011 Feb;12(2):159-70. doi: 10.2217/pgs.10.172.

PMID:
21332310
49.

Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.

Pander J, Wessels JA, Gelderblom H, van der Straaten T, Punt CJ, Guchelaar HJ.

Ann Oncol. 2011 May;22(5):1147-53. doi: 10.1093/annonc/mdq572. Epub 2010 Nov 3.

50.

Genotyping of DNA samples isolated from formalin-fixed paraffin-embedded tissues using preamplification.

Baak-Pablo R, Dezentje V, Guchelaar HJ, van der Straaten T.

J Mol Diagn. 2010 Nov;12(6):746-9. doi: 10.2353/jmoldx.2010.100047. Epub 2010 Sep 16.

Supplemental Content

Loading ...
Support Center